WallStSmart
CTXR

Citius Pharmaceuticals Inc

NASDAQ: CTXR · HEALTHCARE · BIOTECHNOLOGY

$0.70
+16.96% today

Updated 2026-04-30

Market cap
$17.23M
P/E ratio
P/S ratio
4.37x
EPS (TTM)
$-2.46
Dividend yield
52W range
$1 – $2
Volume
0.7M

Citius Pharmaceuticals Inc (CTXR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-20781.00$-20324.00$-20604.00$-705046.00$-2.39M$-5.90M$-7.97M$-11.32M$-12.44M$-16.93M$-24.25M$-28.36M$-29.06M$-28.20M$-26.55M
Capital expenditures$0.00$0.00$0.00$2126.00$2126.00$2126.00$2126.00$1831.00$1831.00$1831.00$40.01M$0.00$2.00$0.00$0.00
Depreciation$1343.00$1343.00$1343.00$2632.00$1753.00$893.00$152364.00$164868.00$179677.00$194316.00$209611.00$214250.00
Stock-based comp$470185.00$486271.00$732151.00$986620.00$779701.00$715983.00$803261.00$1.45M$3.91M$6.62M$11.84M$10.84M
Free cash flow$-20781.00$-20324.00$-20604.00$-707172.00$-2.39M$-5.90M$-7.97M$-11.32M$-12.44M$-16.93M$-64.26M$-28.36M$-29.06M$-28.20M$-26.55M
Investing cash flow$-2.00$255748.00$255748.00$255748.00$-2126.00$-1831.00$-1831.00$-1831.00$-40.01M$-5.00M$-5.75M
Financing cash flow$18493.00$20247.00$20469.00$2.26M$1.51M$5.26M$10.88M$17.30M$11.15M$22.90M$120.47M$31267.00$13.83M$9.97M$33.30M
Dividends paid$0.00
Share repurchases
Debt repayment
Net change in cash$-135.00$-875923.00$-381786.00$2.91M$5.98M$-1.29M$5.97M$56.21M$-28.36M